Interpreting the results of a clinical trial

Keech, Anthony C; Pike, Rhana; Granger, Renee E; Gebski, Val J

doi:10.5694/j.1326-5377.2007.tb00911.x

Topics

Statistics, epidemiology and research design

In preparing an article reporting a clinical trial, the authors are expected to provide a reasoned interpretation of the results and place them into a broader clinical context. “Interpretation” (Item 20 of the CONSORT statement) refers to how the authors account for their results (Box 1).1

Box 1

NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW.

Correspondence: tony@ctc.usyd.edu.au

Competing interests:

None identified.

1. Altman DG, Schulz KF, Moher D, et al, for the CONSORT Group. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001; 134: 663-694.
2. Montori VM, Jaeschke R, Schunemann HJ, et al. Users’ guide to detecting misleading claims in clinical research reports. BMJ 2004; 329: 1093-1096.
3. Gebski V, Marschner I, Keech AC. Specifying objectives and outcomes for clinical trials. Med J Aust 2002; 176: 491-492. <MJA full text>
4. Burgess DC, Gebski VJ, Keech AC. Baseline data in clinical trials. Med J Aust 2003; 179: 105-107. <MJA full text>
5. Beller EM, Gebski V, Keech AC. Randomisation in clinical trials. Med J Aust 2002; 177: 565-567. <MJA full text>
6. Kirby A, Gebski V, Keech AC. Determining the sample size in a clinical trial. Med J Aust 2002; 177: 256-257. <MJA full text>
7. Cook DI, Gebski VJ, Keech AC. Subgroup analysis in clinical trials. Med J Aust 2004; 180: 289-291. <MJA full text>
8. Simes RJ, Gebski VJ, Keech AC. Subgroup analysis: application to individual patient decisions. Med J Aust 2004; 180: 467-469. <MJA full text>
9. Seale JP, Gebski VJ, Keech AC. Generalising the results of trials to clinical practice. Med J Aust 2004; 181: 558-560. <MJA full text>
10. Keech AC, Wonders SM, Cook DI, Gebski VJ. Balancing the outcomes: reporting adverse events. Med J Aust 2004; 181: 215-218. <MJA full text>
11. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998; 339: 1349-1357.
12. Loten C, Stokes B, Worsley D, et al. A randomised controlled trial of hot water (45°C) immersion versus ice packs for pain relief in bluebottle stings. Med J Aust 2006; 184: 329-333. <MJA full text>
13. Ursin G, Bernstein L, Lord SJ, et al. Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer 2005; 93: 364-371.
14. Collins R, Armitage J, Parish S, et al; Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003; 361: 2005-2016.
15. Horton R. The hidden research paper. JAMA 2002; 287: 2775-2778.

Online responses are no longer available. Please refer to our instructions for authors page for more information.